- Report
- November 2026
- 273 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 181 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 181 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 260 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 347 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 190 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 237 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 221 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 383 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 189 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 422 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 238 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 345 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 342 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 573 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 293 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- November 2026
- 411 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- July 2026
- 198 Pages
Global
From €7390EUR$7,990USD£6,167GBP
- Report
- September 2026
- 150 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- August 2026
- 120 Pages
Global
From €4393EUR$4,750USD£3,666GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more